Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study - PubMed (original) (raw)
Randomized Controlled Trial
. 2016 Apr;101(4):1754-61.
doi: 10.1210/jc.2015-3754. Epub 2016 Feb 22.
Affiliations
- PMID: 26900641
- PMCID: PMC4880159
- DOI: 10.1210/jc.2015-3754
Randomized Controlled Trial
Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
Vanita R Aroda et al. J Clin Endocrinol Metab. 2016 Apr.
Abstract
Context: Vitamin B12 deficiency may occur with metformin treatment, but few studies have assessed risk with long-term use.
Objective: To assess the risk of B12 deficiency with metformin use in the Diabetes Prevention Program (DPP)/DPP Outcomes Study (DPPOS).
Design: Secondary analysis from the DPP/DPPOS. Participants were assigned to the placebo group (PLA) (n = 1082) or the metformin group (MET) (n = 1073) for 3.2 years; subjects in the metformin group received open-label metformin for an additional 9 years.
Setting: Twenty-seven study centers in the United States.
Patients: DPP eligibility criteria were: elevated fasting glucose, impaired glucose tolerance, and overweight/obesity. The analytic population comprised participants with available stored samples. B12 levels were assessed at 5 years (n = 857, n = 858) and 13 years (n = 756, n = 764) in PLA and MET, respectively.
Intervention: Metformin 850 mg twice daily vs placebo (DPP), and open-label metformin in the metformin group (DPPOS).
Main outcome measures: B12 deficiency, anemia, and peripheral neuropathy.
Results: Low B12 (≤ 203 pg/mL) occurred more often in MET than PLA at 5 years (4.3 vs 2.3%; P = .02) but not at 13 years (7.4 vs 5.4%; P = .12). Combined low and borderline-low B12 (≤ 298 pg/mL) was more common in MET at 5 years (19.1 vs 9.5%; P < .01) and 13 years (20.3 vs 15.6%; P = .02). Years of metformin use were associated with increased risk of B12 deficiency (odds ratio, B12 deficiency/year metformin use, 1.13; 95% confidence interval, 1.06–1.20). Anemia prevalence was higher in MET, but did not differ by B12 status. Neuropathy prevalence was higher in MET with low B12 levels.
Conclusions: Long-term use of metformin in DPPOS was associated with biochemical B12 deficiency and anemia. Routine testing of vitamin B12 levels in metformin-treated patients should be considered.
Trial registration: ClinicalTrials.gov NCT00038727.
Figures
Figure 1.
Percentage of participants with anemia by vitamin B12 status, 5 and 13 years after randomization (DPPOS years 1 and 9). PLA, placebo.
Comment in
- Diabetes: Metformin linked to vitamin B12 deficiency.
Holmes D. Holmes D. Nat Rev Endocrinol. 2016 Jun;12(6):312. doi: 10.1038/nrendo.2016.39. Epub 2016 Mar 11. Nat Rev Endocrinol. 2016. PMID: 26965381 No abstract available.
Similar articles
- Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes.
Kim J, Ahn CW, Fang S, Lee HS, Park JS. Kim J, et al. Medicine (Baltimore). 2019 Nov;98(46):e17918. doi: 10.1097/MD.0000000000017918. Medicine (Baltimore). 2019. PMID: 31725641 Free PMC article. - The changing cost to prevent diabetes: A retrospective analysis of the Diabetes Prevention Program.
Carris NW, Cheng F, Kelly WN. Carris NW, et al. J Am Pharm Assoc (2003). 2017 Nov-Dec;57(6):717-722. doi: 10.1016/j.japh.2017.05.015. Epub 2017 Aug 12. J Am Pharm Assoc (2003). 2017. PMID: 28807660 - Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes.
Sato Y, Ouchi K, Funase Y, Yamauchi K, Aizawa T. Sato Y, et al. Endocr J. 2013;60(12):1275-80. doi: 10.1507/endocrj.ej13-0332. Epub 2013 Sep 8. Endocr J. 2013. PMID: 24018893 - Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.
Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM; Diabetes Prevention Program Research Group. Aroda VR, et al. Diabetologia. 2017 Sep;60(9):1601-1611. doi: 10.1007/s00125-017-4361-9. Epub 2017 Aug 2. Diabetologia. 2017. PMID: 28770322 Free PMC article. Review. - Metformin and Vitamin B12 Deficiency: Where Do We Stand?
Ahmed MA. Ahmed MA. J Pharm Pharm Sci. 2016 Jul-Sep;19(3):382-398. doi: 10.18433/J3PK7P. J Pharm Pharm Sci. 2016. PMID: 27806244 Review.
Cited by
- Metformin dampens the progression of cholangiofibrosis induced by thioacetamide using deep learning.
Li C, Deng Y, Pan Y, Liao X, Xie H, Xue X, Yu S, Yu W, Yu G. Li C, et al. Heliyon. 2024 Sep 7;10(18):e37347. doi: 10.1016/j.heliyon.2024.e37347. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39309781 Free PMC article. - Vitamin B12 Deficiency in Patients Taking Metformin: Pathogenesis and Recommendations.
Ramzan NUH, Shahjahan K, Dhillon RA, Khan NTA, Hashmat MB, Anwer MU, Ahmed D, Afzal F, Tahir MM, Muzaffar A. Ramzan NUH, et al. Cureus. 2024 Sep 3;16(9):e68550. doi: 10.7759/cureus.68550. eCollection 2024 Sep. Cureus. 2024. PMID: 39233729 Free PMC article. Review. - Innate immunity in peripheral tissues is differentially impaired under normal and endotoxic conditions in aging.
Noh JY, Han HW, Kim DM, Giles ED, Farnell YZ, Wright GA, Sun Y. Noh JY, et al. Front Immunol. 2024 Aug 16;15:1357444. doi: 10.3389/fimmu.2024.1357444. eCollection 2024. Front Immunol. 2024. PMID: 39221237 Free PMC article. - 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association.
Moon JS, Kang S, Choi JH, Lee KA, Moon JH, Chon S, Kim DJ, Kim HJ, Seo JA, Kim MK, Lim JH, Song YJ, Yang YS, Kim JH, Lee YB, Noh J, Hur KY, Park JS, Rhee SY, Kim HJ, Kim HM, Ko JH, Kim NH, Kim CH, Ahn J, Oh TJ, Kim SK, Kim J, Han E, Jin SM, Bae J, Jeon E, Kim JM, Kang SM, Park JH, Yun JS, Cha BS, Moon MK, Lee BW. Moon JS, et al. Diabetes Metab J. 2024 Jul;48(4):546-708. doi: 10.4093/dmj.2024.0249. Epub 2024 Jul 26. Diabetes Metab J. 2024. PMID: 39091005 Free PMC article. No abstract available. - Metformin-Induced Vitamin B12 Deficiency in Patients with Type 2 Diabetes: A Narrative Review with a Practical Approach for Screening, Diagnosing, and Managing Vitamin B12 Deficiency.
Yazidi M, Kammoun E, Oueslati I, Chihaoui M. Yazidi M, et al. Korean J Fam Med. 2024 Jul;45(4):189-198. doi: 10.4082/kjfm.24.0090. Epub 2024 Jul 18. Korean J Fam Med. 2024. PMID: 39054838 Free PMC article.
References
- Berchtold P, Bolli P, Arbenz U, Keiser G. Disturbance of intestinal absorption following metformin therapy (observations on the mode of action of biguanides) [in German]. Diabetologia. 1969;5:405–412. - PubMed
- Beulens JW, Hart HE, Kuijs R, Kooijman-Buiting AM, Rutten GE. Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin. Acta Diabetol. 2015;52:47–53. - PubMed
- de Groot-Kamphuis DM, van Dijk PR, Groenier KH, Houweling ST, Bilo HJ, Kleefstra N. Vitamin B12 deficiency and the lack of its consequences in type 2 diabetes patients using metformin. Neth J Med. 2013;71:386–390. - PubMed
- Haeusler S, Parry-Strong A, Krebs JD. The prevalence of low vitamin B12 status in people with type 2 diabetes receiving metformin therapy in New Zealand–a clinical audit. N Z Med J. 2014;127:8–16. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 DK048412/DK/NIDDK NIH HHS/United States
- U01 DK048375/DK/NIDDK NIH HHS/United States
- U01 DK048434/DK/NIDDK NIH HHS/United States
- U01 DK048413/DK/NIDDK NIH HHS/United States
- U01 DK048468/DK/NIDDK NIH HHS/United States
- U01 DK048387/DK/NIDDK NIH HHS/United States
- U01 DK048404/DK/NIDDK NIH HHS/United States
- U01 DK048407/DK/NIDDK NIH HHS/United States
- U01 DK048437/DK/NIDDK NIH HHS/United States
- U01 DK048406/DK/NIDDK NIH HHS/United States
- UL1 TR001409/TR/NCATS NIH HHS/United States
- R01 DK078907/DK/NIDDK NIH HHS/United States
- U01 DK048397/DK/NIDDK NIH HHS/United States
- U01 DK048381/DK/NIDDK NIH HHS/United States
- U01 DK048514/DK/NIDDK NIH HHS/United States
- U01 DK048485/DK/NIDDK NIH HHS/United States
- U01 DK048411/DK/NIDDK NIH HHS/United States
- P30 DK020541/DK/NIDDK NIH HHS/United States
- U01 DK048443/DK/NIDDK NIH HHS/United States
- U01 DK048380/DK/NIDDK NIH HHS/United States
- U01 DK048400/DK/NIDDK NIH HHS/United States
- U01 DK048489/DK/NIDDK NIH HHS/United States
- U01 DK048349/DK/NIDDK NIH HHS/United States
- U01 DK048377/DK/NIDDK NIH HHS/United States
- P30 DK017047/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous